GlassScriptPhysician profile
Andrew Shapiro
NPI 1215019161
$2,387.48
in general payments reported to CMS, 2019-2025
27 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $163 · 2021: $80.47 · 2022: $119 · 2023: $567 · 2024: $222 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $501.54 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $339.60 | 2019-2020 | |
| Medtronic Vascular, INC. | $153.08 | 2019 | |
| Nevro Corp. | $148.80 | 2023 | Senza |
| Smith+Nephew, INC. | $145.73 | 2023 | Grafix Pl |
| Wright Medical Technology, INC. | $142.86 | 2019 | |
| Amgen INC. | $125.00 | 2025 | Krystexxa |
| Abbvie INC. | $121.81 | 2023 | Dalvance |
| Averitas Pharma INC. | $110.60 | 2023 | Qutenza |
| Biocomposites INC | $100.00 | 2025 | Stimulan |
| Kowa Pharmaceuticals America, INC. | $78.98 | 2022-2023 | Seglentis |
| Sandoz INC. | $54.33 | 2019-2021 | |
| Zyla Life Sciences, INC. | $46.75 | 2019 | |
| Depuy Synthes Sales INC. | $44.75 | 2025 | |
| Alfasigma USA, INC. | $37.78 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $28.31 | 2025 | Physio-Stim |
| Treace Medical Concepts, INC. | $23.89 | 2022 | |
| Focal Therapeutics, INC. | $22.28 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.86 | 2022 | |
| Dynasplint Systems INC. | $19.75 | 2019 | |
| Bioventus LLC | $19.14 | 2021 | |
| Advanced Oxygen Therapy INC. | $18.89 | 2025 | Topical Oxygen Chamber For Extremities |
| Assertio Therapeutics, INC. | $17.97 | 2020 | |
| Horizon Therapeutics Plc | $17.88 | 2022 | |
| Sebela Pharmaceuticals INC. | $16.76 | 2023 | Naftin, Pramosone |
| Melinta Therapeutics, LLC | $15.68 | 2019 | |
| Iroko Pharmaceuticals, LLC | $14.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.